BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore(Dana-Farber Cancer Institute), Ghayas C. Issa(Dana-Farber Cancer Institute), Madeleine E. Lemieux(Dana-Farber Cancer Institute), Peter B. Rahl(Whitehead Institute for Biomedical Research), Junwei Shi(Cold Spring Harbor Laboratory), Hannah M. Jacobs(Dana-Farber Cancer Institute), Efstathios Kastritis(Dana-Farber Cancer Institute), Timothy Gilpatrick(Dana-Farber Cancer Institute), Ronald M. Paranal(Dana-Farber Cancer Institute), Jun Qi(Dana-Farber Cancer Institute), Marta Chesi(Mayo Clinic in Arizona), Anna C. Schinzel(Dana-Farber Cancer Institute), Michael R. McKeown(Dana-Farber Cancer Institute), Timothy P. Heffernan(Dana-Farber Cancer Institute), Christopher R. Vakoc(Cold Spring Harbor Laboratory), P. Leif Bergsagel(Mayo Clinic in Arizona), Irene M. Ghobrial(Harvard University), Paul G. Richardson(Harvard University), Richard A. Young(Whitehead Institute for Biomedical Research), William C. Hahn(Broad Institute), Kenneth C. Anderson(Harvard University), Andrew L. Kung(Dana-Farber Cancer Institute), James E. Bradner(Harvard University), Constantine S. Mitsiades(Harvard University)
Cell
September 1, 2011
10.1016/j.cell.2011.08.017
Cited by 2,834Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis